Effect of dietary reinforcement combined or not with GLP-1 receptor agonist therapy on histological outcomes in MASLD among patients with type 2 diabetes

IF 4.6 2区医学 Q1 ENDOCRINOLOGY & METABOLISM

Diabetes & metabolism Pub Date : 2025-06-19 DOI:10.1016/j.diabet.2025.101679

Bruno Guerci , Michael Joubert , Ghassan Riachi , Marie-Lauren Antoine , Delphine Clabaut , Renaud Fay , Gaetan Prevost

引用次数: 0

查看原文本刊更多论文

膳食强化联合或不联合GLP-1受体激动剂治疗对2型糖尿病MASLD患者组织学结局的影响

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Diabetes & metabolism 医学-内分泌学与代谢

CiteScore

12.00

自引率

4.20%

发文量

审稿时长

13 days

期刊介绍： A high quality scientific journal with an international readership Official publication of the SFD, Diabetes & Metabolism, publishes high-quality papers by leading teams, forming a close link between hospital and research units. Diabetes & Metabolism is published in English language and is indexed in all major databases with its impact factor constantly progressing. Diabetes & Metabolism contains original articles, short reports and comprehensive reviews.